Cargando…
Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice
Purpose: Insulin-like growth factor-1 (IGF-1) stimulates epithelial regeneration but may also induce life-threatening hypoglycemia. In our study, we first assessed its safety. Subsequently, we examined the effect of IGF-1 administered in different dose regimens on gastrointestinal damage induced by...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277384/ https://www.ncbi.nlm.nih.gov/pubmed/35847048 http://dx.doi.org/10.3389/fphar.2022.663855 |
_version_ | 1784745967067594752 |
---|---|
author | Pejchal, Jaroslav Tichy, Ales Kmochova, Adela Fikejzlova, Lenka Kubelkova, Klara Milanova, Marcela Lierova, Anna Filipova, Alzbeta Muckova, Lubica Cizkova, Jana |
author_facet | Pejchal, Jaroslav Tichy, Ales Kmochova, Adela Fikejzlova, Lenka Kubelkova, Klara Milanova, Marcela Lierova, Anna Filipova, Alzbeta Muckova, Lubica Cizkova, Jana |
author_sort | Pejchal, Jaroslav |
collection | PubMed |
description | Purpose: Insulin-like growth factor-1 (IGF-1) stimulates epithelial regeneration but may also induce life-threatening hypoglycemia. In our study, we first assessed its safety. Subsequently, we examined the effect of IGF-1 administered in different dose regimens on gastrointestinal damage induced by high doses of gamma radiation. Material and methods: First, fasting C57BL/6 mice were injected subcutaneously with IGF-1 at a single dose of 0, 0.2, 1, and 2 mg/kg to determine the maximum tolerated dose (MTD). The glycemic effect of MTD (1 mg/kg) was additionally tested in non-fasting animals. Subsequently, a survival experiment was performed. Animals were irradiated ((60)Co; 14, 14.5, or 15 Gy; shielded head), and IGF-1 was administered subcutaneously at 1 mg/kg 1, 24, and 48 h after irradiation. Simultaneously, mice were irradiated ((60)Co; 12, 14, or 15 Gy; shielded head), and IGF-1 was administered subcutaneously under the same regimen. Jejunum and lung damage were assessed 84 h after irradiation. Finally, we evaluated the effect of six different IGF-1 dosage regimens administered subcutaneously on gastrointestinal damage and peripheral blood changes in mice 6 days after irradiation ((60)Co; 12 and 14 Gy; shielded head). The regimens differed in the number of doses (one to five doses) and the onset of administration (starting at 1 [five regimens] or 24 h [one regimen] after irradiation). Results: MTD was established at 1 mg/kg. MTD mitigated lethality induced by 14 Gy and reduced jejunum and lung damage caused by 12 and 14 Gy. However, different dosing regimens showed different efficacy, with three and four doses (administered 1, 24, and 48 h and 1, 24, 48, and 72 h after irradiation, respectively) being the most effective. The three-dose regimens supported intestinal regeneration even if the administration started at 24 h after irradiation, but its potency decreased. Conclusion: IGF-1 seems promising in the mitigation of high-dose irradiation damage. However, the selected dosage regimen affects its efficacy. |
format | Online Article Text |
id | pubmed-9277384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92773842022-07-14 Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice Pejchal, Jaroslav Tichy, Ales Kmochova, Adela Fikejzlova, Lenka Kubelkova, Klara Milanova, Marcela Lierova, Anna Filipova, Alzbeta Muckova, Lubica Cizkova, Jana Front Pharmacol Pharmacology Purpose: Insulin-like growth factor-1 (IGF-1) stimulates epithelial regeneration but may also induce life-threatening hypoglycemia. In our study, we first assessed its safety. Subsequently, we examined the effect of IGF-1 administered in different dose regimens on gastrointestinal damage induced by high doses of gamma radiation. Material and methods: First, fasting C57BL/6 mice were injected subcutaneously with IGF-1 at a single dose of 0, 0.2, 1, and 2 mg/kg to determine the maximum tolerated dose (MTD). The glycemic effect of MTD (1 mg/kg) was additionally tested in non-fasting animals. Subsequently, a survival experiment was performed. Animals were irradiated ((60)Co; 14, 14.5, or 15 Gy; shielded head), and IGF-1 was administered subcutaneously at 1 mg/kg 1, 24, and 48 h after irradiation. Simultaneously, mice were irradiated ((60)Co; 12, 14, or 15 Gy; shielded head), and IGF-1 was administered subcutaneously under the same regimen. Jejunum and lung damage were assessed 84 h after irradiation. Finally, we evaluated the effect of six different IGF-1 dosage regimens administered subcutaneously on gastrointestinal damage and peripheral blood changes in mice 6 days after irradiation ((60)Co; 12 and 14 Gy; shielded head). The regimens differed in the number of doses (one to five doses) and the onset of administration (starting at 1 [five regimens] or 24 h [one regimen] after irradiation). Results: MTD was established at 1 mg/kg. MTD mitigated lethality induced by 14 Gy and reduced jejunum and lung damage caused by 12 and 14 Gy. However, different dosing regimens showed different efficacy, with three and four doses (administered 1, 24, and 48 h and 1, 24, 48, and 72 h after irradiation, respectively) being the most effective. The three-dose regimens supported intestinal regeneration even if the administration started at 24 h after irradiation, but its potency decreased. Conclusion: IGF-1 seems promising in the mitigation of high-dose irradiation damage. However, the selected dosage regimen affects its efficacy. Frontiers Media S.A. 2022-06-29 /pmc/articles/PMC9277384/ /pubmed/35847048 http://dx.doi.org/10.3389/fphar.2022.663855 Text en Copyright © 2022 Pejchal, Tichy, Kmochova, Fikejzlova, Kubelkova, Milanova, Lierova, Filipova, Muckova and Cizkova. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Pejchal, Jaroslav Tichy, Ales Kmochova, Adela Fikejzlova, Lenka Kubelkova, Klara Milanova, Marcela Lierova, Anna Filipova, Alzbeta Muckova, Lubica Cizkova, Jana Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice |
title | Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice |
title_full | Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice |
title_fullStr | Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice |
title_full_unstemmed | Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice |
title_short | Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice |
title_sort | mitigation of ionizing radiation-induced gastrointestinal damage by insulin-like growth factor-1 in mice |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277384/ https://www.ncbi.nlm.nih.gov/pubmed/35847048 http://dx.doi.org/10.3389/fphar.2022.663855 |
work_keys_str_mv | AT pejchaljaroslav mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice AT tichyales mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice AT kmochovaadela mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice AT fikejzlovalenka mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice AT kubelkovaklara mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice AT milanovamarcela mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice AT lierovaanna mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice AT filipovaalzbeta mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice AT muckovalubica mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice AT cizkovajana mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice |